Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects

Hidradenitis suppurativa (HS) is a chronic, suppurative condition of the pilosebaceous unit. Patients suffering from HS demonstrate a molecular profile in keeping with a state of systemic inflammation and are often found to fit the criteria for a diagnosis of metabolic syndrome (MetS). In this paper...

Full description

Saved in:
Bibliographic Details
Published in:International journal of dermatology 2022-10, Vol.61 (10), p.1175-1186
Main Authors: Mintoff, Dillon, Benhadou, Farida, Pace, Nikolai P., Frew, John W.
Format: Article
Language:English
Subjects:
Epidemiology
Health risks
Inflammation
Literature reviews
Metabolic disorders
Metabolic syndrome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3300-8c61678c814bf6006a47e72d09c5c9bda9ba9dcf9a268c40ada2beb5302fb57d3
cites cdi_FETCH-LOGICAL-c3300-8c61678c814bf6006a47e72d09c5c9bda9ba9dcf9a268c40ada2beb5302fb57d3
container_end_page 1186
container_issue 10
container_start_page 1175
container_title International journal of dermatology
container_volume 61
creator Mintoff, Dillon
Benhadou, Farida
Pace, Nikolai P.
Frew, John W.
description Hidradenitis suppurativa (HS) is a chronic, suppurative condition of the pilosebaceous unit. Patients suffering from HS demonstrate a molecular profile in keeping with a state of systemic inflammation and are often found to fit the criteria for a diagnosis of metabolic syndrome (MetS). In this paper, we review the literature with regards to established data on the prevalence of MetS in HS patients and revise the odds ratio of comorbid disease. Furthermore, we attempt to draw parallels between inflammatory pathways in HS and MetS and evaluate how convergences may explain the risk of comorbid disease, necessitating the need for multidisciplinary care.
doi_str_mv 10.1111/ijd.15910
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2574407351</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2713211950</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3300-8c61678c814bf6006a47e72d09c5c9bda9ba9dcf9a268c40ada2beb5302fb57d3</originalsourceid><addsrcrecordid>eNp1kE1Lw0AQhhdRsFYP_oOAF4Wm3U2ySdeb1K9KxYuel8nuxG7ZZONuovTfm1pPgnMZBp73ZXgIOWd0yoaZmY2eMi4YPSAjluY8zvI0OSQjShmLBeXimJyEsBnONGHZiOhn7KB01qgobBvtXY0RNDpaG-1BY2M6E6LQt23voTOfcB1hazTWxln3bhTYSVQ7i6q34Cc_yW6NHlrsu6ESQouqC6fkqAIb8Ox3j8nb_d3r4jFevTwsFzerWKUppfFc5Swv5mrOsrLKKc0hK7BINBWKK1FqECUIrSoBST5XGQUNSYklT2lSlbzQ6Zhc7ntb7z56DJ2sTVBoLTTo-iATXmQZLVLOBvTiD7pxvW-G72RS7NwwwelAXe0p5V0IHivZelOD30pG5c63HHzLH98DO9uzX8bi9n9QLp9u94lvKpuC3g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2713211950</pqid></control><display><type>article</type><title>Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Mintoff, Dillon ; Benhadou, Farida ; Pace, Nikolai P. ; Frew, John W.</creator><creatorcontrib>Mintoff, Dillon ; Benhadou, Farida ; Pace, Nikolai P. ; Frew, John W.</creatorcontrib><description>Hidradenitis suppurativa (HS) is a chronic, suppurative condition of the pilosebaceous unit. Patients suffering from HS demonstrate a molecular profile in keeping with a state of systemic inflammation and are often found to fit the criteria for a diagnosis of metabolic syndrome (MetS). In this paper, we review the literature with regards to established data on the prevalence of MetS in HS patients and revise the odds ratio of comorbid disease. Furthermore, we attempt to draw parallels between inflammatory pathways in HS and MetS and evaluate how convergences may explain the risk of comorbid disease, necessitating the need for multidisciplinary care.</description><identifier>ISSN: 0011-9059</identifier><identifier>EISSN: 1365-4632</identifier><identifier>DOI: 10.1111/ijd.15910</identifier><language>eng</language><publisher>Hoboken: Blackwell Publishing Ltd</publisher><subject>Epidemiology ; Health risks ; Inflammation ; Literature reviews ; Metabolic disorders ; Metabolic syndrome</subject><ispartof>International journal of dermatology, 2022-10, Vol.61 (10), p.1175-1186</ispartof><rights>2021</rights><rights>International Journal of Dermatology © 2022 International Society of Dermatology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3300-8c61678c814bf6006a47e72d09c5c9bda9ba9dcf9a268c40ada2beb5302fb57d3</citedby><cites>FETCH-LOGICAL-c3300-8c61678c814bf6006a47e72d09c5c9bda9ba9dcf9a268c40ada2beb5302fb57d3</cites><orcidid>0000-0003-3705-0119 ; 0000-0002-4533-8297 ; 0000-0001-5042-3632</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Mintoff, Dillon</creatorcontrib><creatorcontrib>Benhadou, Farida</creatorcontrib><creatorcontrib>Pace, Nikolai P.</creatorcontrib><creatorcontrib>Frew, John W.</creatorcontrib><title>Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects</title><title>International journal of dermatology</title><description>Hidradenitis suppurativa (HS) is a chronic, suppurative condition of the pilosebaceous unit. Patients suffering from HS demonstrate a molecular profile in keeping with a state of systemic inflammation and are often found to fit the criteria for a diagnosis of metabolic syndrome (MetS). In this paper, we review the literature with regards to established data on the prevalence of MetS in HS patients and revise the odds ratio of comorbid disease. Furthermore, we attempt to draw parallels between inflammatory pathways in HS and MetS and evaluate how convergences may explain the risk of comorbid disease, necessitating the need for multidisciplinary care.</description><subject>Epidemiology</subject><subject>Health risks</subject><subject>Inflammation</subject><subject>Literature reviews</subject><subject>Metabolic disorders</subject><subject>Metabolic syndrome</subject><issn>0011-9059</issn><issn>1365-4632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kE1Lw0AQhhdRsFYP_oOAF4Wm3U2ySdeb1K9KxYuel8nuxG7ZZONuovTfm1pPgnMZBp73ZXgIOWd0yoaZmY2eMi4YPSAjluY8zvI0OSQjShmLBeXimJyEsBnONGHZiOhn7KB01qgobBvtXY0RNDpaG-1BY2M6E6LQt23voTOfcB1hazTWxln3bhTYSVQ7i6q34Cc_yW6NHlrsu6ESQouqC6fkqAIb8Ox3j8nb_d3r4jFevTwsFzerWKUppfFc5Swv5mrOsrLKKc0hK7BINBWKK1FqECUIrSoBST5XGQUNSYklT2lSlbzQ6Zhc7ntb7z56DJ2sTVBoLTTo-iATXmQZLVLOBvTiD7pxvW-G72RS7NwwwelAXe0p5V0IHivZelOD30pG5c63HHzLH98DO9uzX8bi9n9QLp9u94lvKpuC3g</recordid><startdate>202210</startdate><enddate>202210</enddate><creator>Mintoff, Dillon</creator><creator>Benhadou, Farida</creator><creator>Pace, Nikolai P.</creator><creator>Frew, John W.</creator><general>Blackwell Publishing Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3705-0119</orcidid><orcidid>https://orcid.org/0000-0002-4533-8297</orcidid><orcidid>https://orcid.org/0000-0001-5042-3632</orcidid></search><sort><creationdate>202210</creationdate><title>Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects</title><author>Mintoff, Dillon ; Benhadou, Farida ; Pace, Nikolai P. ; Frew, John W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3300-8c61678c814bf6006a47e72d09c5c9bda9ba9dcf9a268c40ada2beb5302fb57d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Epidemiology</topic><topic>Health risks</topic><topic>Inflammation</topic><topic>Literature reviews</topic><topic>Metabolic disorders</topic><topic>Metabolic syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mintoff, Dillon</creatorcontrib><creatorcontrib>Benhadou, Farida</creatorcontrib><creatorcontrib>Pace, Nikolai P.</creatorcontrib><creatorcontrib>Frew, John W.</creatorcontrib><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mintoff, Dillon</au><au>Benhadou, Farida</au><au>Pace, Nikolai P.</au><au>Frew, John W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects</atitle><jtitle>International journal of dermatology</jtitle><date>2022-10</date><risdate>2022</risdate><volume>61</volume><issue>10</issue><spage>1175</spage><epage>1186</epage><pages>1175-1186</pages><issn>0011-9059</issn><eissn>1365-4632</eissn><abstract>Hidradenitis suppurativa (HS) is a chronic, suppurative condition of the pilosebaceous unit. Patients suffering from HS demonstrate a molecular profile in keeping with a state of systemic inflammation and are often found to fit the criteria for a diagnosis of metabolic syndrome (MetS). In this paper, we review the literature with regards to established data on the prevalence of MetS in HS patients and revise the odds ratio of comorbid disease. Furthermore, we attempt to draw parallels between inflammatory pathways in HS and MetS and evaluate how convergences may explain the risk of comorbid disease, necessitating the need for multidisciplinary care.</abstract><cop>Hoboken</cop><pub>Blackwell Publishing Ltd</pub><doi>10.1111/ijd.15910</doi><tpages>1186</tpages><orcidid>https://orcid.org/0000-0003-3705-0119</orcidid><orcidid>https://orcid.org/0000-0002-4533-8297</orcidid><orcidid>https://orcid.org/0000-0001-5042-3632</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0011-9059
ispartof International journal of dermatology, 2022-10, Vol.61 (10), p.1175-1186
issn 0011-9059
1365-4632
language eng
recordid cdi_proquest_miscellaneous_2574407351
source Wiley-Blackwell Read & Publish Collection
subjects Epidemiology
Health risks
Inflammation
Literature reviews
Metabolic disorders
Metabolic syndrome
title Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T16%3A26%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolic%20syndrome%20and%20hidradenitis%20suppurativa:%20epidemiological,%20molecular,%20and%20therapeutic%20aspects&rft.jtitle=International%20journal%20of%20dermatology&rft.au=Mintoff,%20Dillon&rft.date=2022-10&rft.volume=61&rft.issue=10&rft.spage=1175&rft.epage=1186&rft.pages=1175-1186&rft.issn=0011-9059&rft.eissn=1365-4632&rft_id=info:doi/10.1111/ijd.15910&rft_dat=%3Cproquest_cross%3E2713211950%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3300-8c61678c814bf6006a47e72d09c5c9bda9ba9dcf9a268c40ada2beb5302fb57d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2713211950&rft_id=info:pmid/&rfr_iscdi=true